Breathe Well Live Well
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium/Formoterol; Drug: Placebo
Sponsors: AstraZeneca; Menarini (Co-Funder)
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Lung Disease News |
Practice Fusion And AstraZeneca Partner for PHM Initiative For Asthma, COPD
Lung Disease News The program provides data-driven insights that can assist members in their commitment to improving care for those suffering with chronic obstructive pulmonary disease (COPD) or asthma. The program is sponsored by AstraZeneca and being advanced by … AstraZeneca and EHR firm to use drug alert system |
View full post on asthma – Google News
|
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for …
Satellite PR News (press release) Where's the asthma and COPD therapies market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page report provides 264 tables, charts, and graphs. Discover … |
View full post on asthma – Google News
|
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for …
PR Newswire (press release) Where's the asthma and COPD therapies market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page report provides 264 tables, charts, and graphs. Discover … |
View full post on asthma – Google News
|
Practice Fusion, AstraZeneca Partner on PHM Initiative for Asthma & COPD
HIT Consultant The program, developed by Practice Fusion and sponsored by AstraZeneca, identifies patients whose current asthma or COPD care does not meet evidence-based clinical guidelines, and then alerts physicians at the point of care via patient charts within … Practice Fusion partners with AstraZeneca Aseptika secures US patent for its innovative respiratory infection test |
View full post on asthma – Google News
HCPLive |
Unique Gene Finding Related to COPD, Asthma, and Certain Cancers
HCPLive Novel treatments for pulmonary conditions, such as asthma and chronic obstructive pulmonary disease (COPD), may be in the cards with new research findings. Researchers from the Washington University School of Medicine in St. Louis (WUSTL) discussed … |
View full post on asthma – Google News
|
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market …
MarketWatch oBenralizumab, a monoclonal antibody jointly being developed by MedImmune and AstraZeneca in Phase 3 trials. Benralizumab is bound to the interleukin-5 receptor (IL-5R?) and is being evaluated to help asthma control and reduce the onset of asthmatic … |
View full post on asthma – Google News
|
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market …
PR Newswire (press release) oBenralizumab, a monoclonal antibody jointly being developed by MedImmune and AstraZeneca in Phase 3 trials. Benralizumab is bound to the interleukin-5 receptor (IL-5R?) and is being evaluated to help asthma control and reduce the onset of asthmatic … |
View full post on asthma – Google News
Medical News Today |
Study uncovers new clues about overproduction of mucus in asthma and COPD
Medical News Today When exposed to the trigger protein CLCA1 (red), human cells begin to express the chloride ion channel TMEM16A (green) on their surface – an interaction researchers believe may be responsible for overproduction of mucus in asthma and COPD. Study sheds new light on asthma, COPD |
View full post on asthma – Google News
|
New research lays groundwork for developing treatments for asthma, COPD
News-Medical.net In diseases such as asthma and chronic obstructive pulmonary disease (COPD), the body produces too much mucus, making breathing difficult. New research from Washington University School of Medicine in St. Louis provides clues to potentially counteract … |
View full post on asthma – Google News